Original ResearchPublished 12 October 2026Reporting signals of selected extrapyramidal adverse events with four newer second-generation antipsychotics: a disproportionality analysis of FAERS spontaneous reportsPan Ma · Qin Xiao · Yunpei Zhao · Xin Zhang · Huan Ma · Dan Chen · Linli XieFrontiers in Pharmacologydoi 10.3389/fphar.2026.1921943
Case ReportPublished 8 October 2026Psychotic symptoms in tyrosine hydroxylase deficiency-associated dopa-responsive dystonia treated with antipsychotics and rTMS: a case reportYue Shen · Hai-Zhi Chen · Liang Lv · Lan-lan FangFrontiers in Psychiatrydoi 10.3389/fpsyt.2026.1920048
Original ResearchPublished 25 August 2026Psychotropic dispensing in Greek adolescents and young adults: national trends and regional variationKonstantinos Kassandros · Maria Samakouri · Maria Panagopoulou · Theodoros Constantinidis · Christos KontogiorgisFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1900494
